(Q73916894)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

D S Richardson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S M Kelsey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S A Johnson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Tighe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J D Cavenagh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A C Newland

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

247-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9387047%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1005879219554

7 November 2019

exact match

0 references

cites work

Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study

1 reference

12 December 2020

Fluorescence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue.

1 reference

12 December 2020

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

1 reference

12 December 2020

Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.

1 reference

12 December 2020

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

1 reference

12 December 2020

Liposomes in haematology

1 reference

12 December 2020

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases

1 reference

12 December 2020

Reducing the cardiotoxicity of the anthracyclines

1 reference

12 December 2020

Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity

1 reference

12 December 2020

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

1 reference

12 December 2020

Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia

1 reference

12 December 2020

Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors

1 reference

12 December 2020

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

1 reference

12 December 2020

Use of daunorubicin in patients with solid tumors

1 reference

12 December 2020

Anthracyclines: cardiotoxicity and its prevention

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome).

1 reference

12 December 2020